FDA updates potential risks with liquid-filled intragastric balloonsThere were no deaths reported in the Orbera and ReShape post-approval studies; however, it should be noted that neither of the studies...
Apollo Endosurgery completes US post-approval ORBERA studyApollo Endosurgery has announced that the FDA has completed the review of the final Post-Approval Study (PAS) Report for the ORBERA...
US obesity organisations call for better testing and labelling of drugs for people with obesity1 day ago